Intel
Incoming wire · every headline scored for the targets it names
Incoming wire · every headline scored for the targets it names
Bernstein Maintains Buy Rating on GE Aerospace, Adjusts Price Target
Moderna and Merck Report Phase 3 Results for Cancer Vaccine
No targets blocked. Every unit is clear to engage.

No news trades open. Herald engages on the next strongly positive, material headline.
UNIT-01 · buys blocked: news veto (-0.6 "Nasdaq Down Over 600 Points; Amazon Shares Fall Following W…") until 2026-10-31T13:39Z
FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI for Crohn's Disease
Netflix Announces Record Share Buybacks and Revised 2026 Financial Guidance
Rhode Island Files Lawsuit Against Meta Over Scam Ads
Citigroup Maintains Buy on Procter & Gamble, Raises Price Target to $187
BNP Paribas Maintains Outperform on Procter & Gamble, Raises Price Target to $189
Truist Financial Maintains Buy Rating and Raises Mastercard Price Target
Truist Securities Maintains Buy on Visa, Raises Price Target to $443
Truist Securities Maintains Buy on Mastercard, Raises Price Target to $674
Meta's Q3 FCF Turns Negative On AI Spend—Q4 Capex Implied At $49B-59B
Philip Morris Expects FY26 Adjusted EPS Range $8.29 - $8.44, EPS Range $7.11 - $7.26
Moderna and Merck Report Phase 3 Results for Cancer Vaccine Combination
American Express Raises Profit Outlook, But Layoff Plans and Rising Costs Draw Scrutiny
Dow Tumbles Over 500 Points; American Express Shares Fall After Q3 Results
American Express Announces Plan to Reduce Global Workforce by 5%
UK Regulator Approves Johnson & Johnson's Oral Psoriasis Treatment
T-Mobile Shares Lose Signal as SpaceX Reportedly Seeks 80,000 Cell Sites to Build a Rival Carrier
Class Action Lawsuit Filed Against Bank of America Corporation
American Express Reports Q3 2026 Financial Results
UNIT-01 · buys blocked: news veto (-0.6 "Meta Platforms Outlook Revised To Negative On Significant U…") until 2026-10-31T21:07Z